Jefferson Life Sciences

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 12, 2026	Juvena Therapeutics	$33.5M Series B	Ben Hemani	Eli Lilly and Company, Laura Lande-Diner, Manta Ray Ventures, Mubadala Capital
Mar 1, 2025	Character Biosciences	$93.0M Series B	Jamie Kasuboski	BoxOne Ventures, Industry Ventures, Innovation Endeavors, KdT Ventures, Lifeforce Capital, Sanofi Ventures, Shane Neman, Joel Dudley, Bausch & Lomb, Catalio Capital Management, Section 32